Abstract:Background: An institutional management protocol for patients with subarachnoid hemorrhage (SAH) based on initial cardiac assessment, permissiveness of negative fluid balances, and use of a continuous albumin infusion as the main fluid therapy for the first 5 days of the intensive care unit (ICU) stay was implemented at our hospital in 2014. It aimed at achieving and maintaining euvolemia and hemodynamic stability to prevent ischemic events and complications in the ICU by reducing periods of hypovolemia or hemodynamic instability. This study aimed at assessing the effect of the implemented management protocol on the incidence of delayed cerebral ischemia (DCI), mortality, and other relevant outcomes in patients with SAH during ICU stay. Methods: We conducted a quasi-experimental study with historical controls based on electronic medical records of adults with SAH admitted to the ICU at a tertiary care university hospital in Cali, Colombia. The patients treated between 2011 and 2014 were the control group, and those treated between 2014 and 2018 were the intervention group. We collected baseline clinical characteristics, cointerventions, occurrence of DCI, vital status after 6 months, neurological status after 6 months, hydroelectrolytic imbalances, and other SAH complication. Multivariable and sensitivity analyses that controlled for confounding and considered the presence of competing risks were used to adequately estimate the effects of the management protocol. The study was approved by our institutional ethics review board before study start. Results: One hundred eighty-nine patients were included for analysis. The management protocol was associated with a reduced incidence of DCI (hazard ratio 0.52 [95% confidence interval 0.33-0.83] from multivariable subdistribution hazards model) and hyponatremia (relative risk 0.55 [95% confidence interval 0.37-0.80]). The management protocol was not associated with higher hospital or long-term mortality, nor with a higher occurrence of other unfavorable outcomes (pulmonary edema, rebleeding, hydrocephalus, hypernatremia, pneumonia). The intervention group also had lower daily and cumulative administered fluids compared with historic controls (p < 0.0001). Conclusions: A management protocol based on hemodynamically oriented fluid therapy in combination with a continuous albumin infusion as the main fluid during the first 5 days of the ICU stay appears beneficial for patients with SAH because it was associated with reduced incidence of DCI and hyponatremia. Proposed mechanisms include improved hemodynamic stability that allows euvolemia and reduces the risk of ischemia, among others.

Preclinical Efficacy of Human Albumin in Subarachnoid Hemorrhage.

Human Albumin Improves Long-Term Behavioral Sequelae after Subarachnoid Hemorrhage Through Neurovascular Remodeling

Abstract T P401: Human Albumin Confers Neurovascular Protection and Long-term Neurobehavioral Improvement after Subarachnoid Hemorrhage

Serum Albumin And Prealbumin Predict The Poor Outcome Of Traumatic Brain Injury

Human albumin attenuates Mincle-associated early neuroinflammatory injury in subarachnoid hemorrhage rats

Albumin Reduces Oxidative Stress and Neuronal Apoptosis Via the ERK/Nrf2/HO-1 Pathway after Intracerebral Hemorrhage in Rats

Protective Effect of Albumin on Vegf and Brain Edema in Acute Ischemia in Rats

Neuroprotective effect and mechanism of hydrogen-rich saline against subarachnoid hemorrhage in rats

Progesterone Attenuates Early Brain Injury after Subarachnoid Hemorrhage in Rats

25% Human Serum Albumin Improves Hemodynamics and Prevents the Need for Nearly All Pre-Hospital Resuscitation in a Rat (Rattus Norvegicus) Model of Trauma and Hemorrhage

Progesterone Alleviates Acute Brain Injury Via Reducing Apoptosis and Oxidative Stress in A Rat Experimental Subarachnoid Hemorrhage Model

Dose-effect of Albumin to the Reduction of Brain Edema and the Improvement of Neurological Deficits Following Fluid Percussion Brain Injury in Rats

Can albumin administration relieve lung injury in trauma/hemorrhagic shock?

Experimental Study on the Efficacy of Site-Specific PEGylated Human Serum Albumins in Resuscitation From Hemorrhagic Shock.

Neuroprotective Effects Of Valproic Acid On Blood-Brain Barrier Disruption And Apoptosis-Related Early Brain Injury In Rats Subjected To Subarachnoid Hemorrhage Are Modulated By Heat Shock Protein 70/Matrix Metalloproteinases And Heat Shock Protein 70/Akt Pathways

Protective Effect of Albumin on Lungs Injury in Traumatic/hemorrhagic Shock Rats.

Effect of an Albumin Infusion Treatment Protocol on Delayed Cerebral Ischemia and Relevant Outcomes in Patients with Subarachnoid Hemorrhage

Albumin adjuvant therapy for acute ischemic stroke with large vessel occlusion (AMASS-LVO): rationale, design, and protocol for a phase 1, open-label, clinical trial

Albumin Resuscitation Protects Against Traumatic/hemorrhagic Shock-Induced Lung Apoptosis in Rats

Observation of the Effect of Human Albumins in Acute Severe Cerebral Infarction Patients

Iso-Oncotic Albumin Mitigates Brain and Kidney Injury in Experimental Focal Ischemic Stroke